Low platelet alpha 2 beta 1 levels in patients with von Willebrand disease type I represents an increased risk factor for bleeding.

被引：0
|
作者：
DiPaola, J
Federici, AB
Sacchi, E
Canciani, MT
Mannucci, PM
Kritzik, M
Kunicki, T
Nugent, D
机构：
[1] SCRIPPS INST,LA JOLLA,CA
[2] A BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,MILAN,ITALY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] THE INCIDENCE OF IMPAIRED BINDING CAPACITY OF VON WILLEBRAND FACTOR TO COLLAGEN TYPES I AND III IN PATIENTS WITH TYPE 1 VON WILLEBRAND DISEASE
    Koloskov, A., V
    Vasileva, M. Yu
    Philippova, O., I
    Chernova, E., V
    Beliaeva, E. L.
    Marchenko, V. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2023, 68 (01): : 62 - 69
  • [42] Age Regulates Desmopressin Responses in Patients with Low Von Willebrand Factor and Type 1 Von Willebrand Disease in the Lovic and Win Studies
    Atiq, Ferdows
    Blok, Robin
    Van Kwawegen, Calvin
    Doherty, Dearbhla
    Lavin, Michelle
    Van Der Bom, Johanna G.
    O'Connell, Niamh
    De Meris, Joke
    Ryan, Kevin
    Schols, Saskia
    Byrne, Mary
    Moenen, Floor
    Van Galen, Karin P. M.
    Preston, Roger J. S.
    Fijnvandraat, Karin
    Baker, Ross
    Meijer, Karina
    James, Paula
    Di Paola, Jorge
    Eikenboom, Jeroen
    O'Donnell, James S.
    Leebeek, Frank W. G.
    BLOOD, 2023, 142
  • [43] Associations of multiple genetic variations with plasma levels of Von Willebrand Factor and clinical phenotype in Iranian patients with Von Willebrand disease type 1
    Zafarani, Alireza
    Tabibian, Shadi
    Barati, Mahmood
    Ghodratnia, Elnaz
    Safa, Majid
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
  • [44] Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: Diagnostic and therapeutic implications
    Michiels, JJ
    van de Velde, A
    van Vliet, HHDM
    van der Planken, M
    Schroyens, W
    Berneman, Z
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02): : 111 - 131
  • [45] Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria
    Gæde, P
    Vedel, P
    Parving, HH
    Pedersen, O
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (10) : 2028 - 2033
  • [46] Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease
    Blann, AD
    Nitu-Whalley, IC
    Lee, CA
    Lip, GYH
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (02) : 135 - 137
  • [47] von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD
    Atiq, Ferdows
    Schutte, Lisette M.
    Looijen, Agnes E. M.
    Boender, Johan
    Cnossen, Marjon H.
    Eikenboom, Jeroen
    de Maat, Moniek P. M.
    Kruip, Marieke J. H. A.
    Leebeek, Frank W. G.
    BLOOD ADVANCES, 2019, 3 (24) : 4147 - 4154
  • [48] THE ROLE OF PLATELET VON-WILLEBRAND-FACTOR IN PLATELET-ADHESION AND THROMBUS FORMATION - A STUDY OF 34 PATIENTS WITH VARIOUS SUBTYPES OF TYPE-I VON-WILLEBRAND DISEASE
    FRESSINAUD, E
    FEDERICI, AB
    CASTAMAN, G
    ROTHSCHILD, C
    RODEGHIERO, F
    BAUMGARTNER, HR
    MANNUCCI, PM
    MEYER, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 327 - 332
  • [49] Statins decrease the risk for postoperative cardiac events in patients with increased levels of von Willebrand factor
    Theilmeier, G.
    Voute, M.
    Van De Luijtgaarden, K. M.
    Winkel, T. A.
    Bakker, E. J.
    Valentijn, T. M.
    Verhagen, H. J. M.
    Kastelein, J.
    Poldermans, D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 511 - 511
  • [50] Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays
    Colpani, Paola
    Baronciani, Luciano
    Cozzi, Giovanna
    Pagliari, Maria Teresa
    Biguzzi, Eugenia
    Peyvandi, Flora
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
12345